A recent academic case study, published on April 22, examined using Amgen Inc’s (NASDAQ:AMGN) Blincyto, a bispecific CD3xCD19 ...

Cullinan shifts focus to autoimmune diseases with CLN-978, targeting systemic lupus erythematosus. Initial trial results show ...

The Cambridge developer said on Tuesday it plans to continue development of its drug, CLN-978, in autoimmune diseases rather ...

Cullinan is the latest company to start off in cancer before straying into the autoimmune space. Developers of CD19 cell ...

Cullinan Oncology, now renamed Cullinan Therapeutics, is riding the growing wave of interest in autoimmune disorders by ...

Pop icon Rihanna is living the American dream, and it includes a serious car collection that'll make your jaw drop. That's ...

Despite expressing gratitude, the visitor also revealed a hint of sadness, acknowledging the unlikelihood of ever owning such ...

Elizabeth Cullinan's literary output was not prodigious—but her memorable characters and close attention to the ...

The sale by Southern African diamond mining company Petra Diamonds of an exceptional blue diamond in its fifth tender cycle ...

Financing includes new and existing leading life sciences institutional investorsProceeds, along with existing cash and cash equivalents, are ...

By Sabela Ojea Shares of Cullinan Oncology on Tuesday jumped after the company said it is expanding its focus toward autoimmune diseases. Shares rose 21% ...